glp 1 diabetes GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1 receptor agonists | How
Description
In a comparison of the two weight loss drug giants, Novo Nordisk has been outpaced by Eli Lilly in terms of revenue growth, yet it surpasses Eli Lilly in profitability
229 Subsequently, evidence of the ileal-brake activity of GLP-1 was further provided using the GLP-1R antagonist exendin 9-39
Outside of its use in diabetes treatment, it has additionally been discovered to aid with weight loss
A., Torre J
